Open AccessSerum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
Author(s) -
Johan Mattsson Ulfstedt,
Per Venge,
Sofia Holmgren,
Gunilla Enblad,
Staffan Eriksson,
Daniël Molin
Publication year - 2021
Publication title -
upsala journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.808
H-Index - 41
eISSN - 2000-1967
pISSN - 0300-9734
DOI - 10.48101/ujms.v126.6119
Subject(s) - medicine , biomarker , lymphoma , antibody , thymidine kinase , hodgkin lymphoma , immunology , gastroenterology , virus , biology , biochemistry , herpes simplex virus
Thymidine kinase 1 (TK1) is an intracellular protein associated with DNA synthesis, expressed during the G1 phase and remained elevated through the M phase, with a potential as a biomarker for cell proliferation. In this study, we explore the possible use of TK1 in Hodgkin lymphoma (HL).